Gene Editing Technologies to Target HBV cccDNA
Hepatitis B virus (HBV) remains a significant cause of mortality and morbidity worldwide, since chronic HBV infection is associated with elevated risk of cirrhosis and hepatocellular carcinoma. Current licensed therapies against HBV efficiently suppress viral replication; however, they do not have s...
Main Authors: | Maria Guadalupe Martinez, Elena Smekalova, Emmanuel Combe, Francine Gregoire, Fabien Zoulim, Barbara Testoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/12/2654 |
Similar Items
-
Dynamics of HBV cccDNA expression and transcription in different cell growth phase
by: Chong Chin-Liew, et al.
Published: (2011-12-01) -
Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
by: Xiaomei Wang, et al.
Published: (2021-01-01) -
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
by: Andrea Magri, et al.
Published: (2022-05-01) -
Mechanism of Hepatitis B Virus cccDNA Formation
by: Lei Wei, et al.
Published: (2021-07-01) -
Evaluation of the HBV liver reservoir with fine needle aspirates
by: Barbara Testoni, et al.
Published: (2023-10-01)